实验性自身免疫性脑脊髓炎
状态5
生物
STAT蛋白
免疫学
贾纳斯激酶
细胞因子
癌症研究
白细胞介素2受体
细胞生物学
信号转导
T细胞
多发性硬化
车站3
免疫系统
作者
Xuebin Liu,Stewart Leung,Chunxia Wang,Zhu Tan,Ji Wang,Taylor B. Guo,Lei Fang,Yonggang Zhao,Bing Wan,Xia Qin,Limin Lü,Runsheng Li,Heng Pan,Ming-Juan Song,Ailian Liu,Jian Hong,Hongtao Lu,Jingwu Z. Zhang
出处
期刊:Nature Medicine
[Nature Portfolio]
日期:2010-01-10
卷期号:16 (2): 191-197
被引量:136
摘要
Interleukin-7 receptor (IL-7R) is genetically associated with susceptibility to multiple sclerosis. Here we describe that IL-7 is essential for survival and expansion of pathogenic T helper type 17 (T(H)17) cells in experimental autoimmune encephalomyelitis (EAE). IL-7 directly expanded effector T(H)17 cells in EAE and human T(H)17 cells from subjects with multiple sclerosis, whereas it was not required for T(H)17 differentiation. IL-7R antagonism rendered differentiated T(H)17 cells susceptible to apoptosis through the inhibition of Janus kinase-signal transducer and activator of transcription-5 (JAK-STAT5) pathway and altered expression of the prosurvival protein Bcl-2 and the proapoptotic protein Bax, leading to decreased severity of EAE. In contrast, T(H)1 and regulatory T (T(reg)) cells were less susceptible to or not affected by IL-7R antagonism in vivo. The selectivity was attributable to minimal expression of IL-7Ralpha in T(reg) cells and correlated with a high level of Socs1 (encoding suppressor of cytokine signaling-1) expression in T(H)1 cells. The study reveals a unique, previously undescribed role of IL-7-IL-7R in T(H)17 cell survival and expansion and has implications in the treatment of autoimmune disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI